MedTrace Logo

Immune Responses to Gluten

NCT05209568 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2025-04-23

No results posted yet for this study

Summary

This is a study of immune responses after eating gluten powder in people with celiac disease and healthy controls.

Conditions

  • Celiac Disease
  • Malabsorption Syndromes
  • Digestive System Disease
  • Intestinal Disease
  • Gastrointestinal Diseases
  • Gluten Sensitivity
  • Celiac Disease in Children

Interventions

DIETARY_SUPPLEMENT

Gluten Powder

Single oral dose of gluten powder

Sponsors & Collaborators

  • Children's Hospital Colorado

    collaborator OTHER

  • Celiac Disease Foundation

    collaborator UNKNOWN

  • Boston Children's Hospital

    lead OTHER

Principal Investigators

  • Jocelyn A Silvester, MD, PhD · Boston Children's Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
101 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-15
Primary Completion
2028-09-30
Completion
2029-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05209568 on ClinicalTrials.gov